What happened, in summary

Anne, 53, learned she had Stage II breast cancer in September 2023 after a mammogram showed an abnormality that needed more testing. She was already working in Taoyuan, so she completed additional tests at another hospital. After researching her diagnosis, she understood her estimated 5-year survival rate to be 90%. Anne’s doctors recommended lumpectomy, chemotherapy, radiation therapy, and targeted therapy, and she moved forward with that plan. Her chemotherapy included paclitaxel. The targeted therapy plan changed midway because her health insurance covered 9 rounds rather than the 18 rounds first discussed by her doctor. Beginning treatment made Anne feel hopeful, relieved, motivated, and even happy. The hardest side effects were hair loss and mucositis, which she managed with medication from her doctor. She also worked on eating healthier each day. Family communication stayed much the same, and she continued to value at least 1 family trip a year. As of 2023, Anne was moving through Stage II breast cancer care with a practical and optimistic outlook. She wanted to save enough money to travel the world and described cancer less as something terrifying than as one part of life’s journey.